Genomma Lab Internacional SAB de CV Stock | LABB.MX | MX01LA010006 | A0Q4TC

Date	Genomma Lab Internacional SAB de CV Price
10/25/2024	25.69 undefined
10/24/2024	25.37 undefined
10/23/2024	24.49 undefined
10/22/2024	24.42 undefined
10/21/2024	24.69 undefined
10/18/2024	24.52 undefined
10/17/2024	24.99 undefined
10/16/2024	24.65 undefined
10/15/2024	24.18 undefined
10/14/2024	23.70 undefined
10/11/2024	23.51 undefined
10/10/2024	23.78 undefined
10/9/2024	23.76 undefined
10/8/2024	24.01 undefined
10/7/2024	22.67 undefined
10/4/2024	22.50 undefined
10/3/2024	23.04 undefined
10/2/2024	23.08 undefined
9/30/2024	22.65 undefined
9/27/2024	22.40 undefined

Date	Genomma Lab Internacional SAB de CV Revenue	Genomma Lab Internacional SAB de CV EBIT	Genomma Lab Internacional SAB de CV Net Income
2027e	20.31 B undefined	4.18 B undefined	3.22 B undefined
2026e	20.86 B undefined	4.47 B undefined	2.9 B undefined
2025e	19.32 B undefined	4.11 B undefined	2.18 B undefined
2024e	17.85 B undefined	3.7 B undefined	1.89 B undefined
2023	16.47 B undefined	3.26 B undefined	1.08 B undefined
2022	16.82 B undefined	3.24 B undefined	1.39 B undefined
2021	15.49 B undefined	3.06 B undefined	1.31 B undefined
2020	13.87 B undefined	2.77 B undefined	1.4 B undefined
2019	12.71 B undefined	2.33 B undefined	749.61 M undefined
2018	11.79 B undefined	2.42 B undefined	1.11 B undefined
2017	12.08 B undefined	2.58 B undefined	1.28 B undefined
2016	11.32 B undefined	286.61 M undefined	-1.68 B undefined
2015	11.04 B undefined	-975.22 M undefined	-1.07 B undefined
2014	11.54 B undefined	2.45 B undefined	1.44 B undefined
2013	11.36 B undefined	2.93 B undefined	1.75 B undefined
2012	9.8 B undefined	2.49 B undefined	1.57 B undefined
2011	8.08 B undefined	2.06 B undefined	1.4 B undefined
2010	6.26 B undefined	1.62 B undefined	1.07 B undefined
2009	4.43 B undefined	1.09 B undefined	759 M undefined
2008	2.63 B undefined	673 M undefined	516 M undefined
2007	1.87 B undefined	453 M undefined	304 M undefined
2006	1.43 B undefined	279 M undefined	180 M undefined
2005	693 M undefined	-126 M undefined	-114 M undefined

	Revenue	EBIT	Net Income
2005	693 M MXN	-126 M MXN	-114 M MXN
2006	1.43 B MXN	279 M MXN	180 M MXN
2007	1.87 B MXN	453 M MXN	304 M MXN
2008	2.63 B MXN	673 M MXN	516 M MXN
2009	4.43 B MXN	1.09 B MXN	759 M MXN
2010	6.26 B MXN	1.62 B MXN	1.07 B MXN
2011	8.08 B MXN	2.06 B MXN	1.4 B MXN
2012	9.8 B MXN	2.49 B MXN	1.57 B MXN
2013	11.36 B MXN	2.93 B MXN	1.75 B MXN
2014	11.54 B MXN	2.45 B MXN	1.44 B MXN
2015	11.04 B MXN	-975.22 M MXN	-1.07 B MXN
2016	11.32 B MXN	286.61 M MXN	-1.68 B MXN
2017	12.08 B MXN	2.58 B MXN	1.28 B MXN
2018	11.79 B MXN	2.42 B MXN	1.11 B MXN
2019	12.71 B MXN	2.33 B MXN	749.61 M MXN
2020	13.87 B MXN	2.77 B MXN	1.4 B MXN
2021	15.49 B MXN	3.06 B MXN	1.31 B MXN
2022	16.82 B MXN	3.24 B MXN	1.39 B MXN
2023	16.47 B MXN	3.26 B MXN	1.08 B MXN
2024e	17.85 B MXN	3.7 B MXN	1.89 B MXN
2025e	19.32 B MXN	4.11 B MXN	2.18 B MXN
2026e	20.86 B MXN	4.47 B MXN	2.9 B MXN
2027e	20.31 B MXN	4.18 B MXN	3.22 B MXN

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023

0.08	0.05	0.06	1.32	1.08	1.45	1.54	0.88	1.76	1.16	1.73	1.85	1.09	1.41	0.9	2.05	1.22	1.5	1.47
0.25	0.48	0.6	0.87	1.27	1.94	3.6	4.8	5.02	4.16	2.07	2.49	2.75	2.92	3.44	4.03	4.23	4.27	3.74
0	0	0	-0.11	0.27	0.23	0.05	0.47	0.68	1.31	1.85	1.87	2.26	2.4	2.87	3.28	3.17	2.49	2.53
0.07	0.15	0.23	0.41	0.63	0.95	1.1	1.03	1.44	1.6	1.16	1.17	1.26	1.7	1.91	2.05	2.2	2.4	1.91
0.03	0.02	0.03	0.13	0.12	0.12	0.33	1.03	1.09	0	0.73	0.42	0.48	0.57	0.7	0.63	0.7	0.65	1.01
0.43	0.7	0.92	2.62	3.37	4.68	6.63	8.22	9.99	8.23	7.54	7.8	7.84	9	9.82	12.04	11.52	11.31	10.67
0.03	0.03	0.05	0.11	0.26	0.43	0.43	0.4	0.41	0.46	0.41	0.37	0.55	1.87	2.22	2.85	3.37	3.59	3.41
0	0	0.08	0	0	0.01	0.01	0.01	0.02	0.02	1.35	1.42	1.47	1.56	0.91	0.91	0.77	0.79	0.73
0	1	79	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0.05	4.34	6.86	7.06	6.47	5.26	5.18	4.94	4.91	4.91	5.17	5.15	4.96
0	0	0	0	0	0	0	0	0	0	45	45	0	51.95	0	0	0	0	0
0.02	0.01	0.07	0.11	0.61	0.72	2.08	0.03	0.08	0.73	1.82	0.82	0.84	0.67	0.67	0.63	0.72	0.76	0.96
0.05	0.04	0.28	0.22	0.87	1.15	2.57	4.78	7.37	8.27	10.09	7.91	8.05	9.08	8.71	9.3	10.02	10.29	10.07
0.48	0.73	1.19	2.84	4.24	5.83	9.19	12.99	17.35	16.5	17.63	15.71	15.89	18.08	18.53	21.34	21.54	21.61	20.74

0.27	0.27	0.27	0.28	0.28	1.93	1.93	1.92	1.91	1.91	1.91	1.91	1.91	1.91	1.91	1.91	1.91	1.91	1.86
0	0	0	1.55	1.55	0	0	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04	0.04
-0.03	0.15	0.4	0.48	1.21	2.16	3.53	5.16	6.82	8.26	7.61	5.51	5.99	6.81	6.76	8.09	9.42	10.05	10.83
-73	-74	-78	4	1	-7	66	5	13	12.83	0	768.78	559.48	97.67	50.04	-53.81	-135.77	-147.71	-1,494.86
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2.34	2.34	2.34
0.17	0.35	0.58	2.31	3.04	4.08	5.53	7.12	8.79	10.23	9.57	8.24	8.51	8.86	8.76	9.99	11.24	11.85	11.23
0.16	0.11	0.08	0.38	0.59	0.97	1.26	1.22	1.64	1.55	0.67	1.03	1.1	1.77	1.88	1.64	1.44	1.79	1.84
0.09	0.1	0.15	0	0	0.01	0.02	0	0.01	0.18	0.03	0	0.01	0.01	0.04	0.03	0.03	0.04	1.06
0	0.04	0.09	0.14	0.43	0.57	0.9	1	0.7	5.46	1.45	1.99	2.18	2.03	2.19	2.93	3	2.67	1.72
44	111	257	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0	0	0	0	0	0	0	0.41	0.81	0.4	0.35	2.07	3.01	0.68	1.57	2.01	2.11	4.85	2.01
0.3	0.37	0.58	0.52	1.03	1.55	2.19	2.63	3.15	7.6	2.5	5.1	6.31	4.49	5.68	6.61	6.57	9.36	6.62
0	0	0	0	0	0	0.97	3.05	4.65	6.51	5.83	3.76	1.69	5.2	4.53	4.47	3.86	1.59	4.23
10	17	20	0	46	67	180	229	660	756.92	1.7	2.27	1.69	100.37	214.82	551.64	554.7	392.73	326.36
3	5	7	5	116	104	286	62	52	67.12	57.52	52.59	840.27	866.4	856.45	858.29	489.14	115.08	114.5
0.01	0.02	0.03	0.01	0.16	0.17	1.44	3.34	5.36	7.33	5.89	3.82	2.53	6.16	5.6	5.88	4.9	2.1	4.67
0.31	0.39	0.61	0.53	1.19	1.72	3.62	5.97	8.52	14.93	8.38	8.92	8.84	10.65	11.28	12.5	11.47	11.45	11.3
0.48	0.73	1.19	2.84	4.23	5.8	9.15	13.1	17.3	25.16	17.95	17.15	17.34	19.51	20.04	22.48	22.71	23.31	22.53

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
-0.12	0.18	0.31	0.54	1.08	1.58	2.03	1.61	2.61	2.12	-1.01	-1.64	1.41	1.11	0.76	1.47	1.31	1.39	1.03
9	8	7	18	32	78	81	66	64	98	118	83	69	81	142	158	170	227	271
-58	12	5	192	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.13	-0.31	-0.26	-0.32	-0.76	-0.82	-2.08	-1.96	-1.05	-0.1	-0.13	1.03	-0.14	0.26	0.11	0.01	-0.34	0.3	0.16
0.05	0.01	0.05	-0.2	0.01	0.5	0.05	0.18	0.25	-1.08	2.21	2.07	0.05	0.11	-0.01	0.07	0.33	0.14	0.79
0	0	0	19	0	0	28	162	278	331	343	356	470	586	660	467	484	627	811
0	0	0	265	196	135	346	186	262	376	456	966	416	664	332	751	838	706	981
0.02	-0.1	0.11	0.23	0.36	1.33	0.09	-0.11	1.87	1.04	1.19	1.54	1.39	1.56	1.01	1.71	1.47	2.05	2.25
-6	-11	-32	-127	-178	-419	-968	-2,688	-2,731	-904	-127	-158	-311	-1,512	-876	-704	-836	-422	-335
13	-6	-172	-124	-524	-418	-974	-2,687	-2,722	-2,759	862	140	-208	-1,366	-844	-663	-765	-282	-165
19	5	-140	2	-345	0	-6	1	9	-1,855	990	298	103	145	31	40	71	140	169
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
0.01	0.07	0.15	-0.26	0	0	0.97	2.49	2.04	1.47	-0.72	-0.35	-1.14	1.16	0.09	0.36	-0.58	0.45	-0.12
-0.18	0	0	1.52	-0.07	-0.05	-0.04	-0.07	-0	-0.01	-0.52	-1.08	-0	-0.13	-0.08	-0.01	-0.16	-0.53	-0.14
-0.17	0.07	0.08	1.14	-0.06	-0.53	0.9	2.23	1.77	1.15	-1.58	-1.65	-1.69	0.47	-0.62	0.19	-1.47	-1.36	-1.68
0	-1	0	-19	6	-484	-33	-189	-267	-307	-337	-225	-554	-554	-632	-157	-341	-498	-830
0	0	-61	-95	0	0	0	0	0	0	0	0	0	0	0	0	-391	-777	-580
-0.14	-0.04	0.02	1.25	-0.24	0.38	0.08	-0.62	0.85	-0.58	0.54	0.12	-0.75	0.32	-0.49	1.18	-0.84	0.24	0.17
12.2	-106.9	73.9	101.9	177	912.8	-879.4	-2,796	-861.1	134.5	1,060.4	1,385.35	1,081.03	50.2	130.33	1,009.9	631.56	1,632.36	1,918.85
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Genomma Lab Internacional SAB de CV Gross margin	Genomma Lab Internacional SAB de CV Profit margin	Genomma Lab Internacional SAB de CV EBIT margin	Genomma Lab Internacional SAB de CV Profit margin
2027e	61.23 %	20.61 %	15.86 %
2026e	61.23 %	21.41 %	13.89 %
2025e	61.23 %	21.25 %	11.3 %
2024e	61.23 %	20.75 %	10.61 %
2023	61.23 %	19.78 %	6.59 %
2022	60.43 %	19.28 %	8.26 %
2021	61.75 %	19.73 %	8.44 %
2020	61.92 %	19.96 %	10.12 %
2019	63.7 %	18.34 %	5.9 %
2018	65.83 %	20.56 %	9.41 %
2017	67.24 %	21.4 %	10.59 %
2016	67.88 %	2.53 %	-14.85 %
2015	65.8 %	-8.83 %	-9.68 %
2014	69.34 %	21.19 %	12.52 %
2013	69.92 %	25.8 %	15.42 %
2012	68.76 %	25.43 %	15.97 %
2011	69.5 %	25.47 %	17.3 %
2010	71.02 %	25.78 %	17.13 %
2009	72.02 %	24.66 %	17.15 %
2008	74.82 %	25.6 %	19.63 %
2007	73.36 %	24.19 %	16.23 %
2006	75.79 %	19.52 %	12.6 %
2005	78.07 %	-18.18 %	-16.45 %

	Gross margin	EBIT margin	Profit margin
2005	78.07 %	-18.18 %	-16.45 %
2006	75.79 %	19.52 %	12.6 %
2007	73.36 %	24.19 %	16.23 %
2008	74.82 %	25.6 %	19.63 %
2009	72.02 %	24.66 %	17.15 %
2010	71.02 %	25.78 %	17.13 %
2011	69.5 %	25.47 %	17.3 %
2012	68.76 %	25.43 %	15.97 %
2013	69.92 %	25.8 %	15.42 %
2014	69.34 %	21.19 %	12.52 %
2015	65.8 %	-8.83 %	-9.68 %
2016	67.88 %	2.53 %	-14.85 %
2017	67.24 %	21.4 %	10.59 %
2018	65.83 %	20.56 %	9.41 %
2019	63.7 %	18.34 %	5.9 %
2020	61.92 %	19.96 %	10.12 %
2021	61.75 %	19.73 %	8.44 %
2022	60.43 %	19.28 %	8.26 %
2023	61.23 %	19.78 %	6.59 %
2024e	61.23 %	20.75 %	10.61 %
2025e	61.23 %	21.25 %	11.3 %
2026e	61.23 %	21.41 %	13.89 %
2027e	61.23 %	20.61 %	15.86 %

Date	Genomma Lab Internacional SAB de CV Sales per Share	Genomma Lab Internacional SAB de CV EBIT per share	Genomma Lab Internacional SAB de CV Earnings per Share
2027e	19.91 undefined	0 undefined	3.16 undefined
2026e	20.45 undefined	0 undefined	2.84 undefined
2025e	18.94 undefined	0 undefined	2.14 undefined
2024e	17.5 undefined	0 undefined	1.86 undefined
2023	17.2 undefined	3.4 undefined	1.13 undefined
2022	16.93 undefined	3.27 undefined	1.4 undefined
2021	15.37 undefined	3.03 undefined	1.3 undefined
2020	13.71 undefined	2.74 undefined	1.39 undefined
2019	12.55 undefined	2.3 undefined	0.74 undefined
2018	11.52 undefined	2.37 undefined	1.08 undefined
2017	12.68 undefined	2.71 undefined	1.34 undefined
2016	10.79 undefined	0.27 undefined	-1.6 undefined
2015	10.53 undefined	-0.93 undefined	-1.02 undefined
2014	11.01 undefined	2.33 undefined	1.38 undefined
2013	10.83 undefined	2.79 undefined	1.67 undefined
2012	9.35 undefined	2.38 undefined	1.49 undefined
2011	7.68 undefined	1.96 undefined	1.33 undefined
2010	5.95 undefined	1.53 undefined	1.02 undefined
2009	4.18 undefined	1.03 undefined	0.72 undefined
2008	2.48 undefined	0.64 undefined	0.49 undefined
2007	2.22 undefined	0.54 undefined	0.36 undefined
2006	1.7 undefined	0.33 undefined	0.21 undefined
2005	0.82 undefined	-0.15 undefined	-0.14 undefined

	Sales per Share	EBIT per share	Earnings per Share
2005	0.82 MXN	-0.15 MXN	-0.14 MXN
2006	1.7 MXN	0.33 MXN	0.21 MXN
2007	2.22 MXN	0.54 MXN	0.36 MXN
2008	2.48 MXN	0.64 MXN	0.49 MXN
2009	4.18 MXN	1.03 MXN	0.72 MXN
2010	5.95 MXN	1.53 MXN	1.02 MXN
2011	7.68 MXN	1.96 MXN	1.33 MXN
2012	9.35 MXN	2.38 MXN	1.49 MXN
2013	10.83 MXN	2.79 MXN	1.67 MXN
2014	11.01 MXN	2.33 MXN	1.38 MXN
2015	10.53 MXN	-0.93 MXN	-1.02 MXN
2016	10.79 MXN	0.27 MXN	-1.6 MXN
2017	12.68 MXN	2.71 MXN	1.34 MXN
2018	11.52 MXN	2.37 MXN	1.08 MXN
2019	12.55 MXN	2.3 MXN	0.74 MXN
2020	13.71 MXN	2.74 MXN	1.39 MXN
2021	15.37 MXN	3.03 MXN	1.3 MXN
2022	16.93 MXN	3.27 MXN	1.4 MXN
2023	17.2 MXN	3.4 MXN	1.13 MXN
2024e	17.5 MXN	0 MXN	1.86 MXN
2025e	18.94 MXN	0 MXN	2.14 MXN
2026e	20.45 MXN	0 MXN	2.84 MXN
2027e	19.91 MXN	0 MXN	3.16 MXN

	Number of stocks
2005	843 M Aktien
2006	843 M Aktien
2007	843 M Aktien
2008	1.06 B Aktien
2009	1.06 B Aktien
2010	1.05 B Aktien
2011	1.05 B Aktien
2012	1.05 B Aktien
2013	1.05 B Aktien
2014	1.05 B Aktien
2015	1.05 B Aktien
2016	1.05 B Aktien
2017	952.49 M Aktien
2018	1.02 B Aktien
2019	1.01 B Aktien
2020	1.01 B Aktien
2021	1.01 B Aktien
2022	993.23 M Aktien
2023	957.34 M Aktien
2024e	957.34 M Aktien
2025e	957.34 M Aktien
2026e	957.34 M Aktien
2027e	957.34 M Aktien

Date	Genomma Lab Internacional SAB de CV Dividend
2027e	0.63 undefined
2026e	0.63 undefined
2025e	0.63 undefined
2024e	0.63 undefined
2023	0.59 undefined
2022	0.76 undefined
2021	0.38 undefined

	Dividend	Dividend (Estimate)
2005	0 MXN	0 MXN
2006	0 MXN	0 MXN
2007	0 MXN	0 MXN
2008	0 MXN	0 MXN
2009	0 MXN	0 MXN
2010	0 MXN	0 MXN
2011	0 MXN	0 MXN
2012	0 MXN	0 MXN
2013	0 MXN	0 MXN
2014	0 MXN	0 MXN
2015	0 MXN	0 MXN
2016	0 MXN	0 MXN
2017	0 MXN	0 MXN
2018	0 MXN	0 MXN
2019	0 MXN	0 MXN
2020	0 MXN	0 MXN
2021	0.38 MXN	0 MXN
2022	0.76 MXN	0 MXN
2023	0.59 MXN	0 MXN
2024e	0 MXN	0.63 MXN
2025e	0 MXN	0.63 MXN
2026e	0 MXN	0.63 MXN
2027e	0 MXN	0.63 MXN

Date	Genomma Lab Internacional SAB de CV Payout ratio
2027e	43.86 %
2026e	43.39 %
2025e	46.19 %
2024e	41.99 %
2023	41.99 %
2022	54.58 %
2021	29.41 %
2020	41.99 %
2019	41.99 %
2018	41.99 %
2017	41.99 %
2016	41.99 %
2015	41.99 %
2014	41.99 %
2013	41.99 %
2012	41.99 %
2011	41.99 %
2010	41.99 %
2009	41.99 %
2008	41.99 %
2007	41.99 %
2006	41.99 %
2005	41.99 %

	Payout ratio
2005	41.99 %
2006	41.99 %
2007	41.99 %
2008	41.99 %
2009	41.99 %
2010	41.99 %
2011	41.99 %
2012	41.99 %
2013	41.99 %
2014	41.99 %
2015	41.99 %
2016	41.99 %
2017	41.99 %
2018	41.99 %
2019	41.99 %
2020	41.99 %
2021	29.41 %
2022	54.58 %
2023	41.99 %
2024e	41.99 %
2025e	46.19 %
2026e	43.39 %
2027e	43.86 %

Date	EPS Estimate	EPS Actual	Quarterly report
9/30/2024	0.5	0.7 (39.11 %)	2024 Q3
6/30/2024	0.46	0.67 (47.06 %)	2024 Q2
3/31/2024	0.43	0.39 (-8.96 %)	2024 Q1
12/31/2023	0.17	-0.12 (-169.2 %)	2023 Q4
9/30/2023	0.47	0.39 (-16.88 %)	2023 Q3
6/30/2023	0.43	0.43 (0.54 %)	2023 Q2
3/31/2023	0.39	0.37 (-4.54 %)	2023 Q1
12/31/2022	0.4	0.27 (-32.69 %)	2022 Q4
9/30/2022	0.44	0.4 (-9.71 %)	2022 Q3
6/30/2022	0.44	0.4 (-8.8 %)	2022 Q2
3/31/2022	0.45	0.34 (-25.26 %)	2022 Q1
12/31/2021	0.42	0.36 (-13.27 %)	2021 Q4
9/30/2021	0.42	0.39 (-7.82 %)	2021 Q3
6/30/2021	0.41	0.38 (-6.4 %)	2021 Q2
3/31/2021	0.38	0.32 (-15.21 %)	2021 Q1
12/31/2020	0.33	0.33 (0.3 %)	2020 Q4
9/30/2020	0.33	0.4 (20.66 %)	2020 Q3
6/30/2020	0.36	0.36 (-0.58 %)	2020 Q2
3/31/2020	0.33	0.37 (12.46 %)	2020 Q1
12/31/2019	0.28	0.25 (-11.85 %)	2019 Q4
9/30/2019	0.28	0.72 (155.77 %)	2019 Q3
6/30/2019	0.3	0.24 (-18.88 %)	2019 Q2
3/31/2019	0.28	0.25 (-9.22 %)	2019 Q1
12/31/2018	0.22	0.25 (12.66 %)	2018 Q4
9/30/2018	0.32	0.23 (-28.57 %)	2018 Q3
6/30/2018	0.32	0.31 (-2.49 %)	2018 Q2
3/31/2018	0.42	0.4 (-4.35 %)	2018 Q1
12/31/2017	0.32	0.36 (12.32 %)	2017 Q4
9/30/2017	0.36	0.24 (-32.77 %)	2017 Q3
6/30/2017	0.38	0.29 (-22.75 %)	2017 Q2
3/31/2017	0.32	0.46 (43.62 %)	2017 Q1
12/31/2016	0.43	0.2 (-51.91 %)	2016 Q4
9/30/2016	0.3	0.49 (64.21 %)	2016 Q3
6/30/2016	0.26	0.35 (35.08 %)	2016 Q2
3/31/2016	0.18	0.35 (90.32 %)	2016 Q1
12/31/2015	0.3	-1.67 (-664.57 %)	2015 Q4
9/30/2015	0.36	0.18 (-50.29 %)	2015 Q3
6/30/2015	0.3	0.38 (26.77 %)	2015 Q2
3/31/2015	0.2	0.13 (-35.64 %)	2015 Q1
12/31/2014	0.84	0.49 (-42.24 %)	2014 Q4
9/30/2014	0.52	0.45 (-13.3 %)	2014 Q3
6/30/2014	0.33	0.29 (-12.25 %)	2014 Q2
3/31/2014	0.23	0.15 (-34.64 %)	2014 Q1
12/31/2013	0.82	0.8 (-2.88 %)	2013 Q4
9/30/2013	0.44	0.44 (-0.83 %)	2013 Q3
6/30/2013	0.32	0.3 (-5.27 %)	2013 Q2
3/31/2013	0.13	1.49 (1,023.68 %)	2013 Q1
12/31/2012	0.71	0.71 (-0.56 %)	2012 Q4
9/30/2012	0.39	0.38 (-3.65 %)	2012 Q3
6/30/2012	0.31	0.26 (-15.03 %)	2012 Q2
3/31/2012	0.18	0.13 (-30.28 %)	2012 Q1
12/31/2011	0.59	0.57 (-3.31 %)	2011 Q4
9/30/2011	0.34	0.37 (8.04 %)	2011 Q3
6/30/2011	0.26	0.25 (-2.98 %)	2011 Q2
3/31/2011	0.13	0.13 (4.8 %)	2011 Q1
12/31/2010	0.44	0.44 (0.09 %)	2010 Q4
9/30/2010	0.26	0.27 (6.67 %)	2010 Q3
6/30/2010	0.21	0.22 (2.82 %)	2010 Q2
9/30/2009	0.19	0.18 (-7.26 %)	2009 Q3
3/31/2009	0.07	0.07 (-0.56 %)	2009 Q1

%	Name	Stocks	Change	Date
30.18651 %	Herrera Aspa (Rodrigo Alonso)	307,902,400	1,886,400	12/31/2022
4.83994 %	Fidelity Management & Research Company LLC	49,367,403	0	2/29/2024
2.45098 %	Skagen AS	25,000,000	2,800,000	2/29/2024
2.44159 %	MFS Investment Management	24,904,187	-112,847	2/29/2024
2.27279 %	The Vanguard Group, Inc.	23,182,419	-660,900	3/31/2024
2.01132 %	Impulsora del Fondo México, S.C.	20,515,473	2,642,559	3/31/2024
1.99452 %	BlackRock Institutional Trust Company, N.A.	20,344,075	442,000	3/31/2024
1.68709 %	Wellington Management Company, LLP	17,208,358	-7,978	2/29/2024
1.37023 %	BlackRock Mexico Operadora SA de CV SOFI	13,976,395	-3,079,238	2/29/2024
1.16014 %	Operadora de Fondos Banorte Ixe S.A. de C.V.	11,833,415	-76,877	2/29/2024
1.09058 %	Dimensional Fund Advisors, L.P.	11,123,951	-48,986	2/29/2024
1.08721 %	Pacific Asset Management LLP	11,089,496	424,400	2/29/2024
0.78452 %	Sanlam Investment Management (Pty) Ltd.	8,002,119	0	12/31/2023
0.76488 %	INVESCO Asset Management Limited	7,801,800	-5,800	12/31/2023
0.61144 %	Swedbank Robur Fonder AB	6,236,714	0	2/29/2024
0.52378 %	Invesco Advisers, Inc.	5,342,600	3,581,300	1/31/2024
0.31704 %	Norges Bank Investment Management (NBIM)	3,233,776	-39,040,443	12/31/2023
0.28108 %	BlackRock Advisors (UK) Limited	2,867,049	17,800	3/31/2024
0.27383 %	American Century Investment Management, Inc.	2,793,114	198,058	3/31/2024
0.24562 %	Mellon Investments Corporation	2,505,291	-145,846	3/31/2024
0.20543 %	BTG Pactual Asset Management	2,095,355	-545,609	1/31/2023
0.13872 %	Dimensional Fund Advisors, Ltd.	1,414,949	0	2/29/2024
0.10693 %	BTG Pactual WM Gestão de Recursos Ltda.	1,090,718	1,089,718	2/29/2024
0.10341 %	State Street Global Advisors (US)	1,054,812	0	2/29/2024
0.07898 %	Operadora de Fondos GBM S.A.B. de C.V.	805,580	0	9/30/2023
0.07271 %	Sherpa Capital	741,675	18,989	2/29/2024
0.06684 %	Nuveen LLC	681,800	0	3/31/2024
0.06536 %	Principal Fondos de Inversión, S.A. de C.V.	666,668	-407,000	2/29/2024
0.05882 %	Principal Administradora General de Fondos S.A.	600,000	0	3/31/2024
0.05290 %	Skandia Operadora de Fondos, S.A. de C.V.	539,601	0	2/29/2024
0.05140 %	Finaccess México, S.A. de C.V.	524,270	0	2/29/2024
0.04637 %	Apo Asset Management GmbH	473,000	-800,000	12/31/2023
0.04322 %	azValor Asset Management SGIIC, SAU	440,867	440,867	12/31/2023
0.03828 %	Allianz Global Investors GmbH	390,500	183,500	1/31/2024
0.03817 %	Vaughan Nelson Investment Management, L.P.	389,287	0	1/31/2024
0.03335 %	Avantis Investors	340,161	2,786	3/31/2024
0.03225 %	Geode Capital Management, L.L.C.	329,000	0	2/29/2024
0.02844 %	Parametric Portfolio Associates LLC	290,100	0	1/31/2024
0.02417 %	Zurich Chile Asset Management Administradora General de Fondos S.A.	246,515	6,515	6/30/2023
0.01961 %	HSBC Global Asset Management (México), S. A. de C. V.	200,000	0	2/29/2024
0.01814 %	State Street Global Advisors Ireland Limited	185,031	8,882	3/31/2024
0.01668 %	HSBC Global Asset Management (UK) Limited	170,103	100,060	1/31/2024
0.01240 %	DFA Australia Ltd.	126,495	10,441	12/31/2023
0.01181 %	Actinver S.A. de C.V.	120,440	0	2/29/2024
0.01118 %	Storebrand Kapitalforvaltning AS	114,000	-21,491	10/31/2023
0.01015 %	Wilmington Trust Investment Advisors, Inc.	103,501	0	2/29/2024
0.00934 %	Sura Investment Management México, S.A. de C.V.	95,243	-6,975	2/29/2024
0.00925 %	Fidelity Investments Canada ULC	94,396	-2,207	12/31/2023
0.00880 %	Renta 4 Gestora, S.G.I.I.C., S.A.	89,791	-389	12/31/2023
0.00779 %	Vanguard Global Advisers LLC	79,500	900	2/29/2024
0.00771 %	Segall Bryant & Hamill, LLC	78,600	0	2/29/2024
0.00705 %	Operadora Inbursa de Sociedades de Inversión, S.A. de C.V.	71,870	0	2/29/2024
0.00618 %	Fidelity Institutional Asset Management	63,051	1,675	8/31/2023
0.00502 %	Vanguard Investments Australia Ltd.	51,188	387	2/29/2024
0.00499 %	Irish Life Investment Managers Ltd.	50,919	0	2/29/2024
0.00219 %	Vector Fondos S.A. de C.V. SOFI	22,328	-1,381	2/29/2024
0.00214 %	Operadora de Fondo NAFINSA S.A. de C.V.	21,808	0	4/30/2023
0.00129 %	Natixis Investment Managers SA	13,186	0	8/31/2023
0.00106 %	Monex Operadora de Fondos S.A. de C.V.	10,800	0	2/29/2024
0.00100 %	Dimensional Fund Advisors Canada ULC	10,200	0	11/30/2023
0.00001 %	Compass Group, L.L.C.	100	0	12/31/2023
0.00000 %	Operadora Mifel S.A. de C.V.	48	0	2/29/2024
0 %	Cedar Street Asset Management LLC	0	-104,280	12/31/2022
0 %	ITAU USA Asset Management Inc.	0	-325,459	6/30/2023
0 %	ÖKOWORLD LUX S.A.	0	-1,000,000	6/30/2023
0 %	River Global Investors LLP	0	-108,612	1/31/2023
0 %	Compass Investments de México, S.A. - Sociedad Operadora de Sociedades	0	-290,326	3/31/2023
0 %	SEI Investments Management Corporation	0	-793,400	6/30/2023
0 %	Operadora Valmex de Sociedades de Inversión S.A. de C.V.	0	-641,691	5/31/2023
0 %	Invex Operadora, S.A. de C.V.	0	-157,719	8/31/2023
0 %	Lingohr & Partner Asset Management GmbH	0	-127,200	11/30/2023
0 %	Redwheel	0	-70,100	7/31/2022
0 %	TimesSquare Capital Management, LLC	0	-16,700	6/30/2023
0 %	Larrain Vial Administradora General de Fondos S.A.	0	-2,940,557	3/31/2023
0 %	SEB Asset Management (Denmark)	0	-3,388,432	11/30/2022
0 %	HSBC Global Asset Management (Brazil)	0	-589,000	11/30/2022
0 %	Fiera Capital (UK) Limited	0	-2,127,939	11/30/2022
0 %	Scotia Fondos, S.A. de C.V.	0	-1,470,338	3/31/2023
0 %	Gestión Santander Mexico S.A. de C.V.	0	-4,552,469	6/30/2023
0 %	Danske Capital Finland Oy	0	-319,928	12/31/2022
0 %	J O Hambro Capital Management Limited	0	-244,700	6/30/2023
0 %	Ashmore Investment Management Limited	0	-106,800	7/31/2023
0 %	AllianceBernstein Japan Ltd.	0	-1,145,124	8/31/2023
0 %	Federated Hermes International	0	-1,322,514	9/30/2023
0 %	Baring Asset Management Ltd.	0	-1,479,300	2/28/2023
0 %	Schroder Investment Management Ltd. (SIM)	0	-55,600	6/30/2023
0 %	BNP Paribas Investment Partners SGR SpA	0	-93,506	9/30/2022
0 %	SEB Investment Management AB	0	-161,200	9/30/2022
0 %	Schroder Investment Management North America Inc.	0	-34,900	6/30/2023
0 %	Mackenzie Financial Corporation	0	-5,781	9/30/2023
0 %	Loomis, Sayles & Company, L.P.	0	-13,186	9/30/2023
0 %	Lazard Asset Management, L.L.C.	0	-36,100	8/31/2023
0 %	Florida State Board of Administration	0	-626,220	9/30/2022
0 %	Northern Trust Investments, Inc.	0	-296,100	12/31/2023
0 %	AllianceBernstein L.P.	0	-5,405,217	3/31/2023
0 %	California State Teachers Retirement System	0	-6,573,681	6/30/2023
0 %	JP Morgan Asset Management	0	-597,715	10/31/2022
0 %	Adasina Social Capital	0	-37,163	12/31/2023

What values and corporate philosophy does Genomma Lab Internacional SAB de CV represent?

Genomma Lab Internacional SAB de CV represents a strong focus on innovation, quality, and consumer satisfaction. With a commitment to research and development, the company aims to provide innovative healthcare and personal care products to improve the lives of consumers. Genomma Lab Internacional SAB de CV's corporate philosophy revolves around integrity, transparency, and ethical practices, ensuring the highest standards in all aspects of its operations. The company continuously strives to meet customer needs and exceed expectations through its diverse portfolio of trusted brands. Genomma Lab Internacional SAB de CV's dedication towards excellence sets it apart in the industry.

In which countries and regions is Genomma Lab Internacional SAB de CV primarily present?

Genomma Lab Internacional SAB de CV is primarily present in Mexico and various countries across Latin America. With a strong presence in Mexico, the company has expanded its operations to other key regions including Brazil, Central America, Colombia, and Argentina. Genomma Lab focuses on developing, manufacturing, and distributing a wide range of personal care and pharmaceutical products. With its commitment to providing high-quality health and wellness solutions, the company continues to strengthen its position in these markets while also seeking opportunities for global expansion.

What significant milestones has the company Genomma Lab Internacional SAB de CV achieved?

Genomma Lab Internacional SAB de CV has achieved several significant milestones throughout its history. One notable milestone was the company's listing on the Mexican Stock Exchange in 2008, which marked its transition to a publicly traded company. Additionally, Genomma Lab has successfully expanded its product portfolio, with a strong focus on personal care and pharmaceutical products. The company's commitment to innovation and strategic acquisitions has led to its presence in over 100 countries worldwide. Genomma Lab's continued growth and market leadership have solidified its position as a prominent player in the global healthcare industry.

What is the history and background of the company Genomma Lab Internacional SAB de CV?

Genomma Lab Internacional SAB de CV is a renowned Mexican company specializing in the production and marketing of pharmaceutical and personal care products. Founded in 1996, Genomma Lab has grown to become one of the leading consumer healthcare companies in Latin America. With a diverse portfolio of well-known brands, they offer a wide range of products, including over-the-counter medications, skincare, hair care, and oral care products. Genomma Lab is committed to innovation, quality, and providing affordable healthcare solutions to its customers. With a strong presence in various Latin American countries and a solid track record, Genomma Lab continues to strengthen its position in the global market.

Who are the main competitors of Genomma Lab Internacional SAB de CV in the market?

The main competitors of Genomma Lab Internacional SAB de CV in the market are well-established pharmaceutical companies such as Johnson & Johnson, Procter & Gamble, and Unilever. These companies compete with Genomma Lab in various product categories, including personal care, over-the-counter medicines, and healthcare products. Despite facing competition from these global giants, Genomma Lab has managed to establish a strong presence in the market with its diverse product portfolio and effective marketing strategies.

In which industries is Genomma Lab Internacional SAB de CV primarily active?

Genomma Lab Internacional SAB de CV is primarily active in the healthcare and personal care industries.

What is the business model of Genomma Lab Internacional SAB de CV?

The business model of Genomma Lab Internacional SAB de CV revolves around the development, production, and marketing of pharmaceutical and personal care products. With a focus on innovation and quality, Genomma Lab aims to provide effective solutions for consumers' health and well-being. The company utilizes its extensive research and development capabilities to create a diverse range of products that cater to various market segments. Genomma Lab's business model combines strategic partnerships, robust distribution networks, and aggressive marketing strategies to promote its brand and drive sales. By constantly adapting to market trends and consumer demands, Genomma Lab strives to maintain its position as a leading player in the healthcare and personal care industry.

What is the P/E ratio of Genomma Lab Internacional SAB de CV 2024?

The Genomma Lab Internacional SAB de CV P/E ratio is 12.99.

What is the P/S ratio of Genomma Lab Internacional SAB de CV 2024?

The Genomma Lab Internacional SAB de CV P/S ratio is 1.38.

What is the Quality Investing of Genomma Lab Internacional SAB de CV?

The Quality Investing for Genomma Lab Internacional SAB de CV is 5/10.

What is the revenue of Genomma Lab Internacional SAB de CV 2024?

The expected Genomma Lab Internacional SAB de CV revenue is 17.85 B MXN.

How high is the profit of Genomma Lab Internacional SAB de CV 2024?

The expected Genomma Lab Internacional SAB de CV profit is 1.89 B MXN.

What is the business model of Genomma Lab Internacional SAB de CV

Genomma Lab Internacional SAB de CV is a leading pharmaceutical and health products company based in Mexico. The company specializes in the development, manufacturing, and distribution of over-the-counter (OTC) and cosmetic products. The company divides its business activities into six segments: 1. Medical Products: Genomma Lab offers a range of medical products for the treatment of various diseases such as arthritis, diabetes, dehydration, stomach problems, and other conditions. 2. Cosmetics: Genomma Lab offers a wide range of cosmetic products that can improve the skin's appearance. These include products for acne, skin blemishes, scars, and stretch marks. 3. Hair Care Products: The company offers products in this segment that help structure the hair, improve hair shine, and work against hair loss and damage. 4. Foot Care: Genomma Lab offers a wide selection of foot care products that effectively tackle fungal infections, sweaty feet, and general foot discomfort. 5. Women's Health: Genomma Lab has developed products that can help women with various issues such as menstrual discomfort, vaginal fungus, and sexual dysfunction. 6. Animal Health: Under this segment, Genomma Lab offers a range of products that can treat and heal dogs, cats, and other pets. Genomma Lab also markets well-known brands such as Tío Nacho, Cicatricure, Goicoechea, Asepxia, and Silka Medic. The company has a broad distribution network and sells its products in various countries such as Mexico, the United States, Canada, Colombia, Chile, Peru, and others. Genomma Lab's business model is based on the utilization of advanced technologies and collaboration with leading experts to develop high-quality products. The company places great emphasis on research and development and has established multiple R&D centers. Genomma Lab pursues a differentiated distribution model based on its direct sales channel. Through the direct sales model, Genomma can deliver its products directly to the end customer and thus be more responsive to customer needs. The company also works with retail partners to sell its products in physical stores and online platforms. In summary, Genomma Lab's business model is focused on the development and marketing of innovative OTC and cosmetic products. The company has established itself in various business areas and pursues a differentiated distribution strategy to sell its products both online and in retail. The company leverages advancements in technology and places great importance on research and development to remain a trusted company.

What is the Genomma Lab Internacional SAB de CV dividend?

Genomma Lab Internacional SAB de CV pays a dividend of 0.76 MXN distributed over payouts per year.

How often does Genomma Lab Internacional SAB de CV pay dividends?

The dividend cannot currently be calculated for Genomma Lab Internacional SAB de CV or the company does not pay out a dividend.

What is the Genomma Lab Internacional SAB de CV ISIN?

The ISIN of Genomma Lab Internacional SAB de CV is MX01LA010006.

What is the Genomma Lab Internacional SAB de CV WKN?

The WKN of Genomma Lab Internacional SAB de CV is A0Q4TC.

What is the Genomma Lab Internacional SAB de CV ticker?

The ticker of Genomma Lab Internacional SAB de CV is LABB.MX.

How much dividend does Genomma Lab Internacional SAB de CV pay?

Over the past 12 months, Genomma Lab Internacional SAB de CV paid a dividend of 0.59 MXN . This corresponds to a dividend yield of about 2.29 %. For the coming 12 months, Genomma Lab Internacional SAB de CV is expected to pay a dividend of 0.63 MXN.

What is the dividend yield of Genomma Lab Internacional SAB de CV?

The current dividend yield of Genomma Lab Internacional SAB de CV is 2.29 %.

When does Genomma Lab Internacional SAB de CV pay dividends?

Genomma Lab Internacional SAB de CV pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Genomma Lab Internacional SAB de CV?

Genomma Lab Internacional SAB de CV paid dividends every year for the past 7 years.

What is the dividend of Genomma Lab Internacional SAB de CV?

For the upcoming 12 months, dividends amounting to 0.63 MXN are expected. This corresponds to a dividend yield of 2.46 %.

In which sector is Genomma Lab Internacional SAB de CV located?

Genomma Lab Internacional SAB de CV is assigned to the 'Health' sector.

Wann musste ich die Aktien von Genomma Lab Internacional SAB de CV kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Genomma Lab Internacional SAB de CV from 9/17/2024 amounting to 0.2 MXN, you needed to have the stock in your portfolio before the ex-date on 9/13/2024.

When did Genomma Lab Internacional SAB de CV pay the last dividend?

The last dividend was paid out on 9/17/2024.

What was the dividend of Genomma Lab Internacional SAB de CV in the year 2023?

In the year 2023, Genomma Lab Internacional SAB de CV distributed 0.763 MXN as dividends.

In which currency does Genomma Lab Internacional SAB de CV pay out the dividend?

The dividends of Genomma Lab Internacional SAB de CV are distributed in MXN.

Scope 1 - Direct Emissions	2,737.47
Scope 2 - Indirect emissions from purchased energy	4,041.11
Scope 3 - Indirect emissions within the value chain	43,467
Total CO₂ emissions	6,778.58
CO₂ reduction strategy	✅
Coal energy	❌
Nuclear power	❌
Animal experiments	❌
Fur & Leather	—
Pesticides	—
Palm Oil	—
Tobacco	❌
Genetically modified organisms	❌
Climate concept	—
Sustainable forestry	—
Recycling regulations	✅
Environmentally friendly packaging	✅
Hazardous substances	✅
Fuel consumption and efficiency	❌
Water consumption and efficiency	✅

Percentage of female employees	50.3
Percentage of women in management	—
Percentage of Asian employees	—
Share of Asian management	—
Percentage of Hispanic/Latino employees	—
Hispano/Latino Management share	—
Percentage of Black employees	—
Black Management Share	—
Percentage of white employees	—
White Management Share	—
Adult content	❌
Alcohol	❌
Weapons	—
Firearms	❌
Gambling	❌
Military contracts	❌
Human rights concept	✅
Privacy concept	—
Occupational health and safety	✅
Catholic	❌

Environmental reporting	✅
Stakeholder Engagement	✅
Call Back Policies	❌
Antitrust law	❌

Stock Exchange	Genomma Lab Internacional SAB de CV Ticker
FRANKFURT	GEKA.F
MEX	LABB.MX
PNK	GNMLF

Genomma Lab Internacional SAB de CV Ticker	Genomma Lab Internacional SAB de CV FIGI
LABB:MM	BBG000G12MW3
LABB:MF	BBG000G12N97
GEKA:GR	BBG000HLBK52
GEKA:GF	BBG000HLBKZ9
GNMLF:US	BBG002QM6BQ9
GNMLF:PQ	BBG002QM6C41
GNMLF:UV	BBG002QM6C69
LABBMXN:X2	BBG00JRTKFH1
LABBMXN:XB	BBG00JRTKFK7
LABBMXN:XH	BBG00JRTKFN4
LABBMXN:XF	BBG00JRTKFQ1
LABBMXN:XE	BBG00JRTKFT8
LABBMXN:XJ	BBG00JRTKFV5
LABBMXN:XL	BBG00JRTKFX3
LABBMXN:XG	BBG00JRTKFY2
LABBMXN:XO	BBG00JRTKG07
LABBMXN:XS	BBG00JRTKG52
LABBMXN:XA	BBG00JRTKG61
LABBMXN:E1	BBG00JRTKG89
LABBMXN:XT	BBG00JRTKG98
LABBMXN:XW	BBG00JRTKGB5
LABBMXN:XU	BBG00JRTKGD3
LABBMXN:XV	BBG00JRTKGF1
LABBMXN:XM	BBG00JRTKGG0
LABBMXN:XQ	BBG00JRTKGK5
LABBMXN:XX	BBG00JRTKGL4
LABBMXN:XZ	BBG00JRTKGN2
LABBMXN:EU	BBG00JRTKGV3
LABB:MU	BBG00JX0PJG5
LABBEUR:X2	BBG00K170WZ9
LABBEUR:XB	BBG00K170X05
LABBEUR:XH	BBG00K170X23
LABBEUR:XF	BBG00K170X50
LABBEUR:XE	BBG00K170X78
LABBEUR:XJ	BBG00K170X87
LABBEUR:XL	BBG00K170X96
LABBEUR:XG	BBG00K170XB3
LABBEUR:XO	BBG00K170XC2
LABBEUR:XS	BBG00K170XH7
LABBEUR:XA	BBG00K170XJ5
LABBEUR:E1	BBG00K170XK3
LABBEUR:XT	BBG00K170XL2
LABBEUR:XW	BBG00K170XM1
LABBEUR:XU	BBG00K170XP8
LABBEUR:XV	BBG00K170XQ7
LABBEUR:XM	BBG00K170XR6
LABBEUR:XQ	BBG00K170XT4
LABBEUR:XX	BBG00K170XV1
LABBEUR:XZ	BBG00K170XW0
LABBEUR:EU	BBG00K170XY8
LABBBRL:EO	BBG00KDTDPC4
LABBBRL:XH	BBG00KDTDPG0
LABBBRL:XF	BBG00KDTDPJ7
LABBBRL:XE	BBG00KDTDPL4
LABBBRL:XJ	BBG00KDTDPM3
LABBBRL:XL	BBG00KDTDPN2
LABBBRL:XG	BBG00KDTDPP0
LABBBRL:XO	BBG00KDTDPQ9
LABBBRL:XS	BBG00KDTDPV3
LABBBRL:XA	BBG00KDTDPW2
LABBBRL:E1	BBG00KDTDPX1
LABBBRL:XT	BBG00KDTDPY0
LABBBRL:XW	BBG00KDTDPZ9
LABBBRL:XU	BBG00KDTDQ05
LABBBRL:XV	BBG00KDTDQ14
LABBBRL:XM	BBG00KDTDQ23
LABBBRL:XQ	BBG00KDTDQ41
LABBBRL:XX	BBG00KDTDQ50
LABBBRL:XZ	BBG00KDTDQ69
LABBBRL:EU	BBG00KDTDQ87

2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e
0.69	1.43	1.87	2.63	4.43	6.26	8.08	9.8	11.36	11.54	11.04	11.32	12.08	11.79	12.71	13.87	15.49	16.82	16.47	17.85	19.32	20.86	20.31
-	106.20	31.07	40.36	68.31	41.56	28.91	21.36	15.93	1.58	-4.32	2.48	6.73	-2.35	7.78	9.11	11.66	8.60	-2.09	8.39	8.24	7.99	-2.67
78.07	75.79	73.36	74.82	72.02	71.02	69.50	68.76	69.92	69.34	65.79	67.87	67.24	65.83	63.70	61.92	61.75	60.43	61.23	-	-	-	-
0.54	1.08	1.37	1.97	3.19	4.45	5.61	6.74	7.94	8	7.27	7.68	8.12	7.76	8.1	8.59	9.56	10.16	10.08	0	0	0	0
-0.13	0.28	0.45	0.67	1.09	1.62	2.06	2.49	2.93	2.45	-0.98	0.29	2.58	2.42	2.33	2.77	3.06	3.24	3.26	3.7	4.11	4.47	4.18
-18.18	19.52	24.19	25.60	24.66	25.78	25.47	25.43	25.80	21.19	-8.83	2.53	21.39	20.55	18.34	19.96	19.73	19.28	19.78	20.75	21.25	21.41	20.61
-0.11	0.18	0.3	0.52	0.76	1.07	1.4	1.57	1.75	1.44	-1.07	-1.68	1.28	1.11	0.75	1.4	1.31	1.39	1.08	1.89	2.18	2.9	3.22
-	-257.89	68.89	69.74	47.09	41.37	30.20	12.03	11.95	-17.58	-173.96	57.30	-176.13	-13.29	-32.46	87.32	-6.84	6.27	-21.96	74.63	15.27	32.77	11.15
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
0.84	0.84	0.84	1.06	1.06	1.05	1.05	1.05	1.05	1.05	1.05	1.05	0.95	1.02	1.01	1.01	1.01	0.99	0.96	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Own the gold standard ✨ in financial data & analytics

Price

Price

TickerLABB.MX

ISINMX01LA010006

WKNA0Q4TC

Genomma Lab Internacional SAB de CV stock price

Price

Overview

Intraday Feature

Total Return and Relative Price Change

Interpretation and Investment

Genomma Lab Internacional SAB de CV Stock Price History

Genomma Lab Internacional SAB de CV Revenue, EBIT, Net Income MX01LA010006 · A0Q4TC

Revenue, EBIT and Profit

Understanding Revenue, EBIT, and Income

Yearly Analysis and Comparisons

Utilizing Expectations for Investment

Investment Insights

Genomma Lab Internacional SAB de CV Revenue, EBIT and net profit per share

Genomma Lab Internacional SAB de CV Income Statement, Balance Sheet, Cash Flow Statement

Keystats

Revenue and Growth

Gross Margin

EBIT and EBIT Margin

Income and Growth

Shares Outstanding

Interpreting Year to Year Comparison

Expectations and Predictions

Balance Sheet

Understanding the Balance Sheet

Assets

Liabilities

Equity

Year-to-Year Analysis

Interpreting the Data

Genomma Lab Internacional SAB de CV stock margins MX01LA010006 · A0Q4TC

Margin

Understanding Gross Margin

EBIT Margin Analysis

Revenue Margin Insights

Interpreting Expectations

Comparative Analysis

Genomma Lab Internacional SAB de CV Margin History

Genomma Lab Internacional SAB de CV Stock Sales Revenue, EBIT, Earnings per Share MX01LA010006 · A0Q4TC

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Genomma Lab Internacional SAB de CV Revenue, EBIT and net profit per share

Genomma Lab Internacional SAB de CV business model

Genomma Lab Internacional SAB de CV SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Genomma Lab Internacional SAB de CV Eulerpool Fair Value

Fair Value

Understanding Fair Value

Income-Based Fair Value

Revenue-Based Fair Value

Dividend-Based Fair Value

Expectations and Forecasts

Comparative Analysis

Genomma Lab Internacional SAB de CV historical P/E ratio, EBIT multiple, and P/S ratio

Genomma Lab Internacional SAB de CV shares outstanding MX01LA010006 · A0Q4TC

Revenue, EBIT and Earnings per share

Revenue Per Share

EBIT Per Share

Income Per Share

Expected Values

Genomma Lab Internacional SAB de CV stock splits

Genomma Lab Internacional SAB de CV dividend history and estimates MX01LA010006 · A0Q4TC

Dividend

Dividend Overview

Interpretation and Use

Investment Strategy

Genomma Lab Internacional SAB de CV Dividend History

Genomma Lab Internacional SAB de CV dividend payout ratio MX01LA010006 · A0Q4TC

Ticker
LABB.MX

ISIN
MX01LA010006

WKN
A0Q4TC